Apple has filed an appeal against the recent import ban on Apple Watch, which was imposed at the request of Masimo, a medical monitoring technology company. The ban was a result of a patent infringement related to the function of blood oxygen level reading, which is incorporated in the watches. The decision to uphold the ban was made by the International Trade Commission (ITC), despite no opposition from President Joe Biden’s administration.
Apple has expressed its disapproval of the ban and is taking actions to return the affected watches to customers as soon as possible. The company has also appealed the ban to the United States Court of Appeals for the Federal Circuit. The ITC rejected Apple’s request to stay the ban during the appeal process, which is expected to last up to a year.
Although sales of the affected Apple Watch models have been halted, they are still available through other retail stores. However, the ban does not apply to the cheaper Apple Watch SE model or previously sold watches.
Masimo has accused Apple of stealing pulse oximetry technology and using it in the popular Apple Watch, leading to an ongoing legal battle between the two companies. This is the second time that the Biden administration has declined to veto an import ban on Apple Watch based on patent infringement complaints.
Apple’s wearable device business, including the Apple Watch, generated $8.28 billion in revenue in the third quarter of 2023.
FAQ
The source of the article is from the blog toumai.es